For instance, in a study by Min Yu and colleagues, lobular ER and PgR positive BC patients were shown to display mainly epithelial CTCs (E-CTCs), whereas mesenchymal CTCs (M-CTCs) were more frequent in TNBC and HER2-enriched subtypes. This evidence concerns the gene ERBB2 and breast cancer.